Free Trial
NASDAQ:PDEX

Pro-Dex (PDEX) Stock Price, News & Analysis

$23.28
+1.03 (+4.63%)
(As of 09/6/2024 ET)
Today's Range
$22.00
$23.91
50-Day Range
$17.13
$23.49
52-Week Range
$14.51
$24.74
Volume
26,474 shs
Average Volume
8,070 shs
Market Capitalization
$79.62 million
P/E Ratio
40.14
Dividend Yield
N/A
Price Target
N/A

Pro-Dex MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.68mentions of Pro-Dex in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$47,306 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.06 out of 5 stars

Medical Sector

522nd out of 910 stocks

Surgical & Medical Instruments Industry

60th out of 95 stocks

PDEX stock logo

About Pro-Dex Stock (NASDAQ:PDEX)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

PDEX Stock Price History

PDEX Stock News Headlines

Pro-Dex (NASDAQ:PDEX) Downgraded by StockNews.com to "Buy"
NASDAQ to crash 50%?
During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...
CB Aug 2024 285.000 call
Pro-Dex, Inc. (PDXN.F)
Pro-Dex, Inc. (PDEX)
NASDAQ to crash 50%?
During the 2020 Covid Crash he called a market reversal - eleven days before the S&P bottomed out... Now, he's saying there are four major cracks forming in the US economy...
How to use Samsung Dex for gaming
Pro-Dex Inc. (co)
Monogram Orthopaedics reports FY results
See More Headlines
Receive PDEX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/05/2024
Today
9/07/2024
Next Earnings (Estimated)
11/07/2024
Fiscal Year End
6/30/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PDEX
Employees
140
Year Founded
N/A

Profitability

Net Income
$7.07 million
Pretax Margin
5.50%

Debt

Sales & Book Value

Annual Sales
$46.09 million
Cash Flow
$2.24 per share
Book Value
$8.91 per share

Miscellaneous

Free Float
1,963,000
Market Cap
$79.62 million
Optionable
Not Optionable
Beta
0.38
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

PDEX Stock Analysis - Frequently Asked Questions

How have PDEX shares performed this year?

Pro-Dex's stock was trading at $17.52 at the start of the year. Since then, PDEX stock has increased by 32.9% and is now trading at $23.28.
View the best growth stocks for 2024 here
.

How were Pro-Dex's earnings last quarter?

Pro-Dex, Inc. (NASDAQ:PDEX) released its quarterly earnings data on Thursday, September, 5th. The medical instruments supplier reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.11. The medical instruments supplier earned $15.03 million during the quarter. Pro-Dex had a trailing twelve-month return on equity of 6.50% and a net margin of 4.13%.

What is Michael J. Berthelot's approval rating as Pro-Dex's CEO?

3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees.

Who are Pro-Dex's major shareholders?

Pro-Dex's top institutional shareholders include Dimensional Fund Advisors LP (1.84%) and Renaissance Technologies LLC (0.36%). Insiders that own company stock include Angelita Rebamontan Domingo, William James Farrell III and Katrina Marie Kramer Philp.
View institutional ownership trends
.

How do I buy shares of Pro-Dex?

Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Pro-Dex own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV) and Alibaba Group (BABA).

This page (NASDAQ:PDEX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners